PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM
Total 13F shares
19,395,520
Share change
-836,932
Total reported value
$118,487,548
Price per share
$6.11
Number of holders
50
Value change
-$2,578,623
Number of buys
20
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q4 2019

As of 31 Dec 2019, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,395,520 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Johnson & Johnson Innovation - JJDC, Inc., Rock Springs Capital Management LP, FARALLON CAPITAL MANAGEMENT LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Ghost Tree Capital, LLC, and DAFNA Capital Management LLC. This page lists 50 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.